AF's-affiliated website thinks a failed clinical t
Post# of 1460
https://www.fiercebiotech.com/biotech/synapto...hare-value
But when AVXL has a successful clinical trial, he attacks the company for supposedly cherry-picking results (AKA doing an in-depth analysis).
I guess it depends on which stock you're pumping, and which stock you're shorting.